GaitherNews Escape the Algorithm
Today --°
Updated
Categories
Space & Physics

Synthetic Cells to Sell Synthetic Biology

Synthetic Cells to Sell Synthetic Biology

In 2019, scientists at the J. Craig Venter Institute announced they had created Synthia, the first organism with a fully synthetic genome: a single-celled bacterium whose entire genetic code was designed and built from scratch in a laboratory rather than inherited from nature. The cell could replicate itself, consume nutrients, and produce waste just like any living organism, yet every instruction written in its DNA came from human researchers typing code into computers and chemists assembling the genetic sequences in test tubes. This achievement sparked an immediate debate that continues today: if humans can design and construct life from nonliving chemicals, have we truly created something alive, or have we simply mimicked the appearance of life?

The journey to Synthia began in 2010 when the same team synthesized the genome of Mycoplasma genitalium, a parasitic bacterium with one of the smallest genomes known to science at just 582,000 base pairs of DNA. Rather than copying nature's existing code, they simplified it further, removing genes that seemed unnecessary for survival in a controlled laboratory environment. They inserted this synthetic genome into a bacterial cell whose own DNA had been removed, and the synthetic DNA took over, replicating and directing the cell's machinery. However, scientists still relied on a natural "chassis" (the cellular framework and machinery) to make life function. Synthia in 2019 represented the next leap: researchers synthesized an even simpler genome of 473,000 base pairs and created an entirely new organism from it, though they still needed to use existing cellular building blocks and chemical processes that nature had perfected over billions of years.

The technical process sounds straightforward in principle but proved extraordinarily difficult in practice. Researchers began with a digital genetic sequence written as a string of chemical letters (A, T, G, and C representing different molecules). They then broke this sequence into manageable chunks and ordered synthetic DNA fragments from laboratories that specialize in gene synthesis. Chemists stitched these fragments together using enzymes, gradually assembling longer and longer strands until they had complete chromosomes. The tricky part came when inserting the synthetic genome into a cell: simply putting DNA into a cell doesn't guarantee it will work. The synthetic instructions had to coordinate seamlessly with the cell's natural machinery for reading DNA and translating it into proteins. It took over 700 attempts before researchers created a version of Synthia that actually functioned.

The question of whether synthetic life is truly "alive" remains genuinely unsettled among scientists, philosophers, and biologists. Life on Earth typically means organisms that can reproduce, maintain internal stability, respond to their environment, and evolve. Synthia does all of these things, yet it depends entirely on laboratory conditions and human-designed genetic instructions rather than evolving naturally through survival pressures. Some argue that defining life by function rather than origin makes sense: if something eats, grows, reproduces, and metabolizes, it is alive, regardless of whether humans designed its genome. Others counter that creating life artificially represents something fundamentally different from life that arose through natural processes and cannot fairly be called the same thing. There is no scientific consensus on where the boundary lies.

The implications of synthetic biology extend far beyond the laboratory. Researchers envision using designer organisms to manufacture medicines, biofuels, and chemicals more efficiently than current methods allow. A synthetic microorganism could be programmed to produce insulin, clean up oil spills, or convert carbon dioxide into useful compounds to help address climate change. However, synthetic organisms also raise serious safety and ethical concerns. Could a designer pathogen accidentally escape a lab and spread disease? Who owns the rights to synthetic life forms? Should humans be creating new organisms at all? These questions have prompted governments and scientific organizations to develop regulations and ethics guidelines, though international standards remain incomplete. Synthia represents not just a scientific milestone but a threshold moment where humanity's ability to create life outpaces our wisdom about using that power responsibly.

Source: Nautilus